BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes

Similar documents
Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing

Robert Okwemba, BSPHS, Pharm.D Philadelphia College of Pharmacy

SCHOOL DISTRICT #22 VERNON DIABETES POLICY

Gayle Curto, RN, BSN, CDE Clinical Coordinator

Bipolar Disorder and Substance Abuse Joseph Goldberg, MD

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes

Results of a Peer Mentoring Intervention in Older Patients with Diabetes: The Care Companion Program

CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT

Elizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller

2. What Should Advocates Know About Diabetes? O

Healthy Living with Diabetes. Diabetes Disease Management Program

Overview Medication Adherence Where Are We Today?

The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care

Survey of Clinical Trial Awareness and Attitudes

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Oklahoma county. Community Health Status Assessment

Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes

Diabetes means you have too much sugar in

Borgess Diabetes Center PATIENT REGISTRATION/DEMOGRAPHICS

Getting the Big Picture

Clinical Impact of An Inpatient Diabetes Care Model. Objectives

Self-management for people with chronic health conditions Innovation Community

Myths About Type 2 Diabetes and Insulin

Type 1 Diabetes. Pennington Nutrition Series. Overview. About Insulin

Social Support, Depression and Treatment Adherence Among Type 2 Diabetes Patients

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

1333 Plaza Blvd, Suite E, Central Point, OR *

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge

EVALUATION OF A BASAL-BOLUS INSULIN PROTOCOL FROM CONTINUING DOSING EFFICACY AND SAFETY OPTIMIZATION IN NON-CRITICALLY ILL HOSPITALIZED PATIENTS

written by Harvard Medical School Insulin Therapy Managing Your Diabetes

SUPPORT KNOWLEDGE QUALIFY PETROCTM

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease

Diabetes Medications: Insulin Therapy

CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy

Breathe With Ease. Asthma Disease Management Program

Managing the Hospitalized Patient on Insulin: Care Transition. Catie Prinzing MSN, APRN, CNS

Behavioral Health Barometer. United States, 2013

Treating Depression to Remission in the Primary Care Setting. James M. Slayton, M.D., M.B.A. Medical Director United Behavioral Health

on a daily basis. On the whole, however, those with heart disease are more limited in their activities, including work.

Type 2 Diabetes workshop notes

Why is Diabetes Important To Your Company?

Chapter 8 - General Discussion

A list of all medications you are taking also include any vitamins, supplements, over-the-counter medicines, or herbal products

CARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS

Using the Flip Chart to Teach

Population Health Management Program

Type 1 diabetes and eating disorders

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure

Algorithms for Glycemic Management of Type 2 Diabetes

Concept Series Paper on Disease Management

MEDICAL POLICY POLICY TITLE DIABETIC SELF-MANAGEMENT TRAINING PROGRAM POLICY NUMBER MP

Attitude towards Insulin Therapy among Patients with Type 2 Diabetes in Tripoli, Libya

Jane Jeffrie Seley DNP, MPH, GNP, CDE, BC-ADM, CDTC Diabetes Nurse Practitioner Division of Endocrinology NewYork-Presbyterian Hospital Weill Cornell

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Baskets of Care Diabetes Subcommittee

2013 Diabetes and Eye Disease Fact Sheet

Introduction. We hope this guide will aide you and your staff in creating a safe and supportive environment for your students challenged by diabetes.

A prospective study on drug utilization pattern of anti-diabetic drugs in rural areas of Islampur, India

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?

Statistics of Type 2 Diabetes

Diabetes Fundamentals

An Overview of Medicare Covered Diabetes Supplies and Services

My Doctor Says I Need to Take Diabetes Pills and Insulin... What Do I Do Now? BD Getting Started. Combination Therapy

DIABETES PACKET. To ensure your child s well-being, please provide the school with the following supplies:

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

Lambeth and Southwark Action on Malnutrition Project (LAMP) Dr Liz Weekes Project Lead Guy s & St Thomas NHS Foundation Trust

Self-Management and Self-Management Support on Chronic Low Back Pain Patients in Primary Care

Insulin/Diabetes Calculations

Myth vs. Reality: Diabetes Related

Welcome to the Emory Diabetes Education Training Academy!

CAHPS Clinician & Group Survey: Overview of the Questionnaires (Four-Point Scale)

Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement

Effect of mental health on long-term recovery following a Road Traffic Crash: Results from UQ SuPPORT study

CARE COORDINATION IN PATIENTS WITH TYPE 2 DIABETES

A Community Pediatric Diabetes Program: Innovation, Technology & Best Practice

Major Depressive Disorders Questions submitted for consideration by workshop participants

Medical Management. G.2 At a Glance. G.3 Procedures Requiring Prior Authorization. G.5 How to Contact or Notify Medical Management

Transcription:

BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective glucose-lowering agent Lower compliance with insulin regimens -associated with higher A1C levels and higher rates of hospital admission In a study using a Department of Veterans Affairs database, insulin use was 77% of prescribed amounts

STUDIES A review in 2005 identified factors associated with adherence to any diabetes medication These factors include: medication costs regimen complexity patient s emotional well-being patient s perceptions of medication side effects medication-related intrusions on activities of daily living

OBJECTIVE The purpose of this study was to assess factors associated with patient frequency of intentionally skipping insulin injections and factors associated with this behavior, in a large sample of patients weighted to be representative of all adult diabetic patients in the U.S. who take insulin.

RESEARCH DESIGN AND METHODS Data were obtained through an Internet survey of U.S. Adults self-identified as taking insulin to treat type 1 or type 2 diabetes. Survey was conducted 13 June to 7 July 2008 by Harris Interactive, a contract research organization. Sample was drawn from the Harris Interactive Chronic Illness Panel. Patients were recruited by email,if they had diabetes and currently used a syringe or insulin pen to deliver insulin. Recruitment quota was 500 participants.

MEASURES Data collected from participants included the following: 1) basic demographic information; 2) disease type, duration, complications, and treatment; 3) perceived burden of insulin injections; 4) the experience of injections; 5) negative affect toward insulin injections; 6) frequency of skipping of insulin injections Respondents reported whether they had ever been diagnosed with type 1 or type 2 diabetes depression, obesity, or CVD and whether they treat their diabetes with diet, exercise, and medications

SAMPLE PROFILE The sample (n 502) was 55% male, 73% white, 11% Hispanic, 11% African American, and 5% other race/ethnicity Mean age of 55 years About 51% had attended college 38% were presently employed, and those not employed included 8% students and 8% disabled; the remainder were mostly retired or nonworking spouses Median annual income of the sample was about $35,000

Result highlights 57% of the respondents reported omitting insulin injections, with 20% omitting insulin injections regularly. Regression analyses identified older age, lower income and education, type 2 diabetes, poor diet adherence, more frequently prescribed injections, interference with daily activities, pain, and embarrassment as independent risk factors for intentional insulin omission. Separate analyses for respondents with type 1 and type 2 diabetes found diet adherence to be a more prominent correlate among type 1 respondents whereas age, education, income, pain, and embarrassment were more prominent among type 2 respondents.

Other relevant findings 32% reported as diagnosed with depression 77% - type 2 diabetes, and the rest with type 1 DM Diabetes for an average of almost 15 years Primary diabetes health care provider 61% PCP 28% endocrinologist 11% named another (non-physician) health care provider. 39% reported engaging in physical activity and 55% said they followed a healthy diet 70% took insulin using a syringe and 30% used a pen 56% changed their needle with each injection

Also.. Patients reported 2.7 injections a day (maximum of five recorded) 22% said they planned their daily activities around their insulin injections Similar proportions reported that insulin injections interfered with their lives 23% said insulin injections interfered with their eating/exercising schedule more than a little 25% said that insulin injections had a negative effect on one or more activity of daily living 22% reported they had to mentally prepare themselves before each injection 33% had some level of dread associated with taking their daily injections 21% reported often worrying about hypoglycemia Scores for pain and inflammation/ bruising were significantly higher than those for embarrassment, time needed, and ease of use, P 0.001

CONCLUSIONS Two aspects of patients treatment regimens were associated with increased insulin omission respondents who took more injections each day and those who did not follow a healthy diet were more likely to skip injections. Although respondents were self-selected and the sample was relatively small to determine the national prevalence of intentional omission of insulin doses Findings suggest that insulin omission is a substantial problem in the clinical care of diabetes. Peyrot et al. also recommend strategies for addressing these risk factors to prevent intentional insulin omission, which can inform clinical practice. Pain and embarrassment influence insulin omission suggests that alternate delivery systems such as an insulin pen system and better preparation for starting insulin may be useful

FACTORS INSULIN AND INJECTION-RELATED Study suggests that insulin omission is affected by the perceived burden of insulin therapy DEMOGRAPHIC & DISEASE FACTORS Respondents with higher household income, were less likely to skip insulin injections as easier access to medications and supplies, more access to diabetes education, higher health literacy no racial/ethnic differences in intentional insulin omission no overall association between age and intentional insulin injection omission among patients with type 1 type 2 diabetes, older respondents were less likely to skip insulin injections consistent with earlier studies Approx 10 15% of pts. with diabetes suffer from co-morbid major depression and diabetes non-adherence

Strengths & Limitations Strengths of the study include the large sample of diabetic patients drawn from a gen population and the sample was weighted to be nationally representative Study appears to be among the first to identify an association between socioeconomic status and insulin omission. No objective measure of insulin use (e.g., pharmacy records). Measure of insulin omission was very specific (i.e., skipping injections that respondents knew they should take), it is possible that some respondents included injections they did not skip intentionally, but rather simply forgot to take. Inclusions may be scheduled injections that were appropriately skipped because a meal was not eaten or blood glucose levels were very low.

EDITORIAL National Health and Nutrition Examination Survey (NHANES) data showed 45% of patients with diabetes did not achieve glycemic targets of 7% Poor insulin adherence is a significant problem for health care delivery Patients may be more likely to adhere to their treatment if they believe it alleviates their diabetes symptoms Providers should address patients perceptions of the benefits of adhering to their treatment Many physicians and patients are resistant to initiate insulin therapy with higher rates of physicians delaying insulin therapy in the U.S. Addressing type 2 diabetic patients concerns about insulin early in the treatment may help minimize or prevent psychological insulin resistance & insulin omission

Other issues Connection between type 1 diabetes and eating disorders is of concern as associated with poor glycemic control, frequent episodes of DKA Restriction or omission of insulin may be an important symptom of a concurrent eating disorder Association of insulin omission and weight (DAWN study), concerns were associated with being female, less educated, diagnosis of type 2 diabetes Poorer insulin taking behaviors among African American and Hispanic patients compared with Caucasians (VA study) Peyrot et al. did not address important issues such as other selfcare behaviors, weight concerns, the impact of insulin delivery systems, and survey reliability and validity Not all insulin omission is motivated by weight issues, and suggest that the assessment of attitudes and beliefs about insulin is important to improve glycemia and diabetes self-management.